Novel 1,8-naphthyridine compounds

Details for Australian Patent Application No. 2008241503 (hide)

Owner Merck & Co., Inc.

Inventors Hale, Jeffrey J.; Kothandaraman, Shankaran; Guiadeen, Deodialsingh

Agent Spruson & Ferguson

Pub. Number AU-A-2008241503

PCT Pub. Number WO2008/130527

Priority 60/925,019 18.04.07 US

Filing date 14 April 2008

Wipo publication date 30 October 2008

International Classifications

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Event Publications

29 October 2009 PCT application entered the National Phase

  PCT publication WO2008/130527 Priority application(s): WO2008/130527

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008241508-Heart sound tracking system and method

2008241500-Aryl heterocyclic CGRP receptor antagonists